<it>Salmonella enterica </it>serotype Virchow associated with human infections in Switzerland: 2004-2009

<p>Abstract</p> <p>Background</p> <p>Salmonellosis is one of the most important foodborne diseases and a major threat to public health. <it>Salmonella </it>serotype Virchow ranks among the top five serovars in Europe.</p> <p>Method</p> <...

Full description

Bibliographic Details
Main Authors: Adank Luzius, Cernela Nicole, Käppeli Ursula, Stephan Roger, Bonalli Mario, Hächler Herbert
Format: Article
Language:English
Published: BMC 2011-02-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/11/49
id doaj-9c26805ad6774a09977fb3d62d69a7a8
record_format Article
spelling doaj-9c26805ad6774a09977fb3d62d69a7a82020-11-25T01:42:59ZengBMCBMC Infectious Diseases1471-23342011-02-011114910.1186/1471-2334-11-49<it>Salmonella enterica </it>serotype Virchow associated with human infections in Switzerland: 2004-2009Adank LuziusCernela NicoleKäppeli UrsulaStephan RogerBonalli MarioHächler Herbert<p>Abstract</p> <p>Background</p> <p>Salmonellosis is one of the most important foodborne diseases and a major threat to public health. <it>Salmonella </it>serotype Virchow ranks among the top five serovars in Europe.</p> <p>Method</p> <p>A total of 153 strains isolated from different patients from 2004 through 2009 in Switzerland were further characterized by (i) assessing phenotypic antibiotic resistance profiles using the disk diffusion method and (ii) by genotyping using pulsed-field gel electrophoresis (PFGE) after macrorestriction with <it>Xba</it>I in order to evaluate strain relationship.</p> <p>Results</p> <p>The relative frequency of <it>S</it>. Virchow among other <it>Salmonella </it>serovars varied between 4<sup>th </sup>to 8<sup>th </sup>rank. The annual incidence ranged from 0.45/100'000 in 2004 to 0.40/100'000 in 2009. A total of 48 strains (32%) were resistant to one to 3 antimicrobials, 54 strains (36%) displayed resistance patterns to more than three antibiotics. No trend was identifiable over the years 2004 to 2009. We found a high prevalence (62%) of nalidixic acid resistant strains, suggesting an equally high rate of decreased fluoroqionolone susceptibility, whereas intermediate resistance to ciprofloxacin was negligible. Two strains were extended spectrum β-lactamase (ESBL) producers. Analysis of PFGE patterns uncovered a predominant cluster (similarity coefficient above 80%) consisting of 104 of the 153 strains.</p> <p>Conclusion</p> <p>The worldwide increase of antibiotic resistances in <it>Salmonella </it>is an emerging public health problem. For Switzerland, no clear trend is identifiable over the years 2004 to 2009 for <it>S</it>. Virchow. Antimicrobial susceptibility and resistance profiles varied considerably within this period. Nevertheless, the situation in Switzerland coincided with findings in other European countries. Genotyping results of this strain collection revealed no evidence for an undetected outbreak within this time period.</p> http://www.biomedcentral.com/1471-2334/11/49
collection DOAJ
language English
format Article
sources DOAJ
author Adank Luzius
Cernela Nicole
Käppeli Ursula
Stephan Roger
Bonalli Mario
Hächler Herbert
spellingShingle Adank Luzius
Cernela Nicole
Käppeli Ursula
Stephan Roger
Bonalli Mario
Hächler Herbert
<it>Salmonella enterica </it>serotype Virchow associated with human infections in Switzerland: 2004-2009
BMC Infectious Diseases
author_facet Adank Luzius
Cernela Nicole
Käppeli Ursula
Stephan Roger
Bonalli Mario
Hächler Herbert
author_sort Adank Luzius
title <it>Salmonella enterica </it>serotype Virchow associated with human infections in Switzerland: 2004-2009
title_short <it>Salmonella enterica </it>serotype Virchow associated with human infections in Switzerland: 2004-2009
title_full <it>Salmonella enterica </it>serotype Virchow associated with human infections in Switzerland: 2004-2009
title_fullStr <it>Salmonella enterica </it>serotype Virchow associated with human infections in Switzerland: 2004-2009
title_full_unstemmed <it>Salmonella enterica </it>serotype Virchow associated with human infections in Switzerland: 2004-2009
title_sort <it>salmonella enterica </it>serotype virchow associated with human infections in switzerland: 2004-2009
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2011-02-01
description <p>Abstract</p> <p>Background</p> <p>Salmonellosis is one of the most important foodborne diseases and a major threat to public health. <it>Salmonella </it>serotype Virchow ranks among the top five serovars in Europe.</p> <p>Method</p> <p>A total of 153 strains isolated from different patients from 2004 through 2009 in Switzerland were further characterized by (i) assessing phenotypic antibiotic resistance profiles using the disk diffusion method and (ii) by genotyping using pulsed-field gel electrophoresis (PFGE) after macrorestriction with <it>Xba</it>I in order to evaluate strain relationship.</p> <p>Results</p> <p>The relative frequency of <it>S</it>. Virchow among other <it>Salmonella </it>serovars varied between 4<sup>th </sup>to 8<sup>th </sup>rank. The annual incidence ranged from 0.45/100'000 in 2004 to 0.40/100'000 in 2009. A total of 48 strains (32%) were resistant to one to 3 antimicrobials, 54 strains (36%) displayed resistance patterns to more than three antibiotics. No trend was identifiable over the years 2004 to 2009. We found a high prevalence (62%) of nalidixic acid resistant strains, suggesting an equally high rate of decreased fluoroqionolone susceptibility, whereas intermediate resistance to ciprofloxacin was negligible. Two strains were extended spectrum β-lactamase (ESBL) producers. Analysis of PFGE patterns uncovered a predominant cluster (similarity coefficient above 80%) consisting of 104 of the 153 strains.</p> <p>Conclusion</p> <p>The worldwide increase of antibiotic resistances in <it>Salmonella </it>is an emerging public health problem. For Switzerland, no clear trend is identifiable over the years 2004 to 2009 for <it>S</it>. Virchow. Antimicrobial susceptibility and resistance profiles varied considerably within this period. Nevertheless, the situation in Switzerland coincided with findings in other European countries. Genotyping results of this strain collection revealed no evidence for an undetected outbreak within this time period.</p>
url http://www.biomedcentral.com/1471-2334/11/49
work_keys_str_mv AT adankluzius itsalmonellaentericaitserotypevirchowassociatedwithhumaninfectionsinswitzerland20042009
AT cernelanicole itsalmonellaentericaitserotypevirchowassociatedwithhumaninfectionsinswitzerland20042009
AT kappeliursula itsalmonellaentericaitserotypevirchowassociatedwithhumaninfectionsinswitzerland20042009
AT stephanroger itsalmonellaentericaitserotypevirchowassociatedwithhumaninfectionsinswitzerland20042009
AT bonallimario itsalmonellaentericaitserotypevirchowassociatedwithhumaninfectionsinswitzerland20042009
AT hachlerherbert itsalmonellaentericaitserotypevirchowassociatedwithhumaninfectionsinswitzerland20042009
_version_ 1725033800171257856